Who Buys Atenolol from India — 671 Importers Behind a $40.6M Market

The importation of Atenolol from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like EVERSANA Life Science Services (United States) and UNICHEM Pharmaceuticals USA Inc. (United States) function as intermediaries, procuring large quantities to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.

• Hospital Groups: Organizations such as HEKO Pharmacy Ltd (Tanzania) and PLANET PHARMA SA (France) represent hospital networks that import Atenolol directly for patient care. Their procurement is typically based on patient demand and formulary requirements, leading to regular, sizable orders.

• Retail Chains: While not explicitly listed among the top buyers, retail pharmacy chains in various countries import Atenolol to meet consumer demand. Their purchasing behavior involves frequent, moderate-sized orders to maintain inventory levels across multiple outlets.

• Government Procurement: Entities like PHARMACEUTICAL & CHEMICAL (Zimbabwe) often engage in government tenders to supply public health facilities. Their procurement is characterized by large, periodic orders aligned with national healthcare programs and budget cycles.

• Re-exporters: Companies such as AUROLOGISTICS LLC (AUROBINDO PHARMA) (United States) may import Atenolol for redistribution to other markets. Their purchasing patterns involve bulk acquisitions to leverage economies of scale and fulfill international orders.

• Contract Manufacturers: Firms like RISING PHARMA HOLDINGS INC (United States) may import Atenolol as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and market demand forecasts.

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Atenolol is FDA-approved. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.

3. Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30049074: Pharmaceutical products under HS code 30049074 are generally duty-free in the United States.

Zimbabwe

1. Regulatory Authority: Medicines Control Authority of Zimbabwe (MCAZ).

2. Import Registration Process: Importers must register Atenolol with MCAZ by submitting a dossier that includes product quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 12 months, depending on the completeness of the submission and MCAZ's review capacity.

4. Import Tariff/Duty for HS 30049074: Pharmaceuticals under this HS code are subject to a 5% import duty in Zimbabwe.

France

1. Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from ANSM, requiring submission of a comprehensive dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The MA process typically takes 12 to 18 months, depending on the complexity of the application and ANSM's review schedule.

4. Import Tariff/Duty for HS 30049074: As an EU member, France applies a 0% import duty on pharmaceutical products under this HS code.

South Africa

1. Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).

2. Import Registration Process: Importers must register Atenolol with SAHPRA by submitting an application that includes product quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 24 months, subject to SAHPRA's review timelines and the completeness of the application.

4. Import Tariff/Duty for HS 30049074: Pharmaceuticals under this HS code are generally duty-free in South Africa.

Netherlands

1. Regulatory Authority: Medicines Evaluation Board (MEB).

2. Import Registration Process: Importers must obtain a Marketing Authorization from the MEB, requiring submission of a dossier that demonstrates the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The process typically takes 12 to 18 months, depending on the complexity of the application and MEB's review capacity.

4. Import Tariff/Duty for HS 30049074: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.

The demand for Atenolol in importing countries is primarily driven by the prevalence of cardiovascular diseases (CVDs), particularly hypertension, which Atenolol is commonly prescribed to manage. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2025. This high prevalence underscores the consistent need for effective antihypertensive medications like Atenolol.

Government healthcare programs and the expansion of universal health coverage (UHC) further bolster demand. Many countries have integrated Atenolol into their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which includes Atenolol as a core medication for managing CVDs. This inclusion facilitates procurement through tender-based purchasing systems, ensuring widespread availability in public health facilities. Additionally, international organizations such as the United Nations Population Fund (UNFPA) and the Global Fund often support the procurement of essential medicines, including Atenolol, to enhance access in low- and middle-income countries.

Our data indicates that between 2022 and 2026, 671 buyers across 124 countries imported Atenolol from India, reflecting its global demand and the critical role it plays in managing cardiovascular health.

The importation of Atenolol from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like EVERSANA Life Science Services (United States) and UNICHEM Pharmaceuticals USA Inc. (United States) function as intermediaries, procuring large quantities to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to ensure consistent supply chains.

• Hospital Groups: Organizations such as HEKO Pharmacy Ltd (Tanzania) and PLANET PHARMA SA (France) represent hospital networks that import Atenolol directly for patient care. Their procurement is typically based on patient demand and formulary requirements, leading to regular, sizable orders.

• Retail Chains: While not explicitly listed among the top buyers, retail pharmacy chains in various countries import Atenolol to meet consumer demand. Their purchasing behavior involves frequent, moderate-sized orders to maintain inventory levels across multiple outlets.

• Government Procurement: Entities like PHARMACEUTICAL & CHEMICAL (Zimbabwe) often engage in government tenders to supply public health facilities. Their procurement is characterized by large, periodic orders aligned with national healthcare programs and budget cycles.

• Re-exporters: Companies such as AUROLOGISTICS LLC (AUROBINDO PHARMA) (United States) may import Atenolol for redistribution to other markets. Their purchasing patterns involve bulk acquisitions to leverage economies of scale and fulfill international orders.

• Contract Manufacturers: Firms like RISING PHARMA HOLDINGS INC (United States) may import Atenolol as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is driven by production schedules and market demand forecasts.

United States

1. Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process: Importers must ensure that Atenolol is FDA-approved. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the reference listed drug.

3. Estimated Timeline for Registration: The ANDA review process typically takes 10 months, though it can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30049074: Pharmaceutical products under HS code 30049074 are generally duty-free in the United States.

Zimbabwe

1. Regulatory Authority: Medicines Control Authority of Zimbabwe (MCAZ).

2. Import Registration Process: Importers must register Atenolol with MCAZ by submitting a dossier that includes product quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 12 months, depending on the completeness of the submission and MCAZ's review capacity.

4. Import Tariff/Duty for HS 30049074: Pharmaceuticals under this HS code are subject to a 5% import duty in Zimbabwe.

France

1. Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from ANSM, requiring submission of a comprehensive dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The MA process typically takes 12 to 18 months, depending on the complexity of the application and ANSM's review schedule.

4. Import Tariff/Duty for HS 30049074: As an EU member, France applies a 0% import duty on pharmaceutical products under this HS code.

South Africa

1. Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).

2. Import Registration Process: Importers must register Atenolol with SAHPRA by submitting an application that includes product quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 24 months, subject to SAHPRA's review timelines and the completeness of the application.

4. Import Tariff/Duty for HS 30049074: Pharmaceuticals under this HS code are generally duty-free in South Africa.

Netherlands

1. Regulatory Authority: Medicines Evaluation Board (MEB).

2. Import Registration Process: Importers must obtain a Marketing Authorization from the MEB, requiring submission of a dossier that demonstrates the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The process typically takes 12 to 18 months, depending on the complexity of the application and MEB's review capacity.

4. Import Tariff/Duty for HS 30049074: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under this HS code.

The demand for Atenolol in importing countries is primarily driven by the prevalence of cardiovascular diseases (CVDs), particularly hypertension, which Atenolol is commonly prescribed to manage. According to the World Health Organization (WHO), CVDs are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2025. This high prevalence underscores the consistent need for effective antihypertensive medications like Atenolol.

Government healthcare programs and the expansion of universal health coverage (UHC) further bolster demand. Many countries have integrated Atenolol into their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which includes Atenolol as a core medication for managing CVDs. This inclusion facilitates procurement through tender-based purchasing systems, ensuring widespread availability in public health facilities. Additionally, international organizations such as the United Nations Population Fund (UNFPA) and the Global Fund often support the procurement of essential medicines, including Atenolol, to enhance access in low- and middle-income countries.

Our data indicates that between 2022 and 2026, 671 buyers across 124 countries imported Atenolol from India, reflecting its global demand and the critical role it plays in managing cardiovascular health.